Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 396

Results For "STI"

7043 News Found

Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’
News | September 27, 2023

Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’

‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic


Hermes Pharma to invest €25 million to bolster manufacturing capabilities
News | September 27, 2023

Hermes Pharma to invest €25 million to bolster manufacturing capabilities

The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing


AIIMS, New Delhi celebrates 68th Foundation Day
News | September 26, 2023

AIIMS, New Delhi celebrates 68th Foundation Day

India is promoting holistic healthcare with emphasis on preventive care


Briefs: Mankind Pharma and Sequent Scientific
News | September 26, 2023

Briefs: Mankind Pharma and Sequent Scientific

Mankind Pharma commences the commercial operations newly set-up plant in Udaipur


India becomes role model in crisis management and preventive healthcare: Dr. Jitendra Singh
News | September 25, 2023

India becomes role model in crisis management and preventive healthcare: Dr. Jitendra Singh

Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua


Indraprastha Apollo Hospitals collaborates with MotoGP Bharat
News | September 25, 2023

Indraprastha Apollo Hospitals collaborates with MotoGP Bharat

The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team


Eurofins opens BioPharma campus in Hyderabad
Biotech | September 25, 2023

Eurofins opens BioPharma campus in Hyderabad

The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies


Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
Clinical Trials | September 23, 2023

Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer

The companies will work with investigators to share the results with the scientific community


Emmes appoints Peter Ronco as CEO
People | September 23, 2023

Emmes appoints Peter Ronco as CEO

Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri


Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021